Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

21.9%

115 terminated/withdrawn out of 525 trials

Success Rate

68.7%

-17.9% vs industry average

Late-Stage Pipeline

11%

56 trials in Phase 3/4

Results Transparency

41%

104 of 252 completed trials have results

Key Signals

94 recruiting104 with results67 terminated48 withdrawn

Enrollment Performance

Analytics

N/A

219(57.2%)

Phase 1

51(13.3%)

Phase 2

43(11.2%)

Phase 4

40(10.4%)

Phase 3

16(4.2%)

Early Phase 1

14(3.7%)

383Total

N/A(219)

Phase 1(51)

Phase 2(43)

Phase 4(40)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (525)

Showing 20 of 525 trials

NCT05014256Not ApplicableCompleted

System Interventions to Achieve Early and Equitable Transplants (STEPS) Study

Role: collaborator

NCT06041321Not ApplicableRecruiting

Novel Bioactive Sleeve on Pain and PROMs

Role: lead

NCT05730283Phase 2Recruiting

Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

Role: collaborator

NCT05273762Not ApplicableRecruiting

Treatment of Low-Risk Submassive Pulmonary Embolism With FlowTriever

Role: lead

NCT06118268Not ApplicableRecruiting

iTBS to Enhance Social Cognition in People With Psychosis

Role: lead

NCT05148156Not ApplicableRecruiting

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

Role: lead

NCT04758624Not ApplicableRecruiting

Elucidating the Temporality of Structural and Functional Connectivity Changes in Essential Tremor After Successful Deep Brain Stimulation to the Dentato-rubro-thalamic Tract

Role: lead

NCT06097845Not ApplicableRecruiting

Transcranial Ultrasound Via Sonolucent Cranioplasty

Role: lead

NCT07163273Phase 2Recruiting

Monthly Alternating NALIRIFOX and GnP in the First-Line Setting for Metastatic Pancreatic Ductal Adenocarcinoma

Role: lead

NCT00745355Active Not Recruiting

Quality of Life in Patients With Bladder Cancer

Role: collaborator

NCT05941000Not ApplicableCompleted

Continuous Glucose Monitoring and Behavioral Change Intervention for People With Type 2 Diabetes and Diabetes Distress

Role: lead

NCT06987565Phase 2Recruiting

Transcutaneous Vagus Nerve Stimulation in SLE

Role: lead

NCT06096207Phase 1Recruiting

DBS for Depression

Role: lead

NCT07809932Recruiting

Breast Artery Calcification (BAC) and Female Cardiovascular Disease

Role: lead

NCT06965452Not ApplicableRecruiting

Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet Arthropathy

Role: lead

NCT04721691Phase 1Completed

Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).

Role: lead

NCT07163793Phase 2Active Not Recruiting

Pilot Study of Reduced Venetoclax Exposure

Role: lead

NCT06934096Not ApplicableRecruiting

Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.

Role: lead

NCT07791290Not ApplicableRecruiting

Vagustim™ Transcutaneous Auricular Vagus Nerve Stimulation Devices

Role: lead

NCT04685772Recruiting

Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches

Role: lead